CHIRAL CROTYLBORONATES: METHODOLOGY AND SYNTHESIS

手性巴豆基硼酸酯:方法学和合成

基本信息

  • 批准号:
    3294876
  • 负责人:
  • 金额:
    $ 17.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1988
  • 资助国家:
    美国
  • 起止时间:
    1988-02-01 至 1996-01-31
  • 项目状态:
    已结题

项目摘要

The efficient stereo- and enantioselective synthesis of complex arrays of acyclic stereocenters constitutes one of the most intriguing challenges in modern synthetic organic chemistry. The multitude of such acyclic arrays in macrolides, polyether antibiotics, complex carbohydrates and numerous other classes of biologically active natural products has provided considerable stimulus for the development of synthetic methodology that is practical, efficient, and applicable to a wide range of problems. The major objectives of this research program continue to be (1) the development of a family of highly enantioselective chiral allyl- and crotylboronates and (2) the application of this technology in the synthesis of biologically active, propionate-derived natural products. The tartrate ester modified allylboronates 1-3 developed in our laboratory function beautifully in matched double asymmetric reactions but often give less satisfactory results in mismatched double asymmetric reactions. Consequently, additional effort will be devoted to the development of improved, second generation reagents 63 and 68-70. Our observation that the % e.e. of the allylborations of unsaturated aldehydes is significantly enhanced by using metal carbonyl complexes as substrate surrogates will be applied in enantioselective syntheses of carbocyclin and of a key rutamycin B intermediate (124). Syntheses of streptovaricin D and bafilomycin A1 initiated in the previous grant period will be completed, and syntheses of zincophorin and rutamycin B will be initiated in the later years of this grant. Methods for construction the unusual quinone methide unit of streptovaricin D must be developed. A stereochemical study of the reactions of gamma-methoxyallylchromium and chiral aldehydes will be completed in connection with the bafilomycin synthesis, and additional studies into the factors that control the stereochemistry of the bafilomycin aldol coupling reaction (55 and 28) will be performed. Aldol reactions for fragment assembly steps in the rutamycin synthesis also will be examined. These studies provide the opportunity to define the stereochemical preferences of the Lewis acid catalyzed aldol reactions of enol silanes prepared from chiral alpha-methyl ketones, the results of which will be of considerable significance particularly if substantial selectivity is observed.
立体选择性和对映选择性合成的复杂阵列

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM R ROUSH其他文献

WILLIAM R ROUSH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM R ROUSH', 18)}}的其他基金

Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
癌症治疗中的靶向酪蛋白激酶 1d/e (CK1d/1e)
  • 批准号:
    8631767
  • 财政年份:
    2014
  • 资助金额:
    $ 17.97万
  • 项目类别:
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
癌症治疗中的靶向酪蛋白激酶 1d/e (CK1d/1e)
  • 批准号:
    8840911
  • 财政年份:
    2014
  • 资助金额:
    $ 17.97万
  • 项目类别:
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
癌症治疗中的靶向酪蛋白激酶 1d/e (CK1d/1e)
  • 批准号:
    9049453
  • 财政年份:
    2014
  • 资助金额:
    $ 17.97万
  • 项目类别:
SAR Analysis/Med Chem (Florida)
SAR 分析/Med Chem(佛罗里达)
  • 批准号:
    8538725
  • 财政年份:
    2012
  • 资助金额:
    $ 17.97万
  • 项目类别:
SAR Analysis/Med Chem (Florida)
SAR 分析/Med Chem(佛罗里达)
  • 批准号:
    8120939
  • 财政年份:
    2010
  • 资助金额:
    $ 17.97万
  • 项目类别:
SAR Analysis/Med Chem (Florida)
SAR 分析/Med Chem(佛罗里达)
  • 批准号:
    8332835
  • 财政年份:
    2008
  • 资助金额:
    $ 17.97万
  • 项目类别:
SYNTHETIC CHEMISTRY
合成化学
  • 批准号:
    6816899
  • 财政年份:
    2004
  • 资助金额:
    $ 17.97万
  • 项目类别:
SYNTHESIS OF INHIBITORS OF PARASITIC CYSTEINE PROTEASES
寄生半胱氨酸蛋白酶抑制剂的合成
  • 批准号:
    6338609
  • 财政年份:
    2000
  • 资助金额:
    $ 17.97万
  • 项目类别:
SYNTHESIS OF INHIBITORS OF PARASITIC CYSTEINE PROTEASES
寄生半胱氨酸蛋白酶抑制剂的合成
  • 批准号:
    6099783
  • 财政年份:
    1999
  • 资助金额:
    $ 17.97万
  • 项目类别:
SYNTHESIS OF CRUZAIN INHIBITORS
CruzAIN抑制剂的合成
  • 批准号:
    6268162
  • 财政年份:
    1998
  • 资助金额:
    $ 17.97万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了